FDA Clearance Tracker · P900009-S049
EXOGEN® Ultrasound Bone Healing System
Last checked: Nov 20, 2026Latest source record: Dec 21, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Dec 21, 2023
Approved
Time to decision
154 days
Received Jul 20, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class II
The decision
- FDA number
- P900009-S049
- Device name
- EXOGEN® Ultrasound Bone Healing System
- Applicant
- Bioventus, LLC
- Applicant location
- Durham, NC
- Received
- Jul 20, 2023
- Decided
- Dec 21, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P900009
Device type
- Device type
- Stimulator, bone growth, non-invasive (LOF)
- Device class
- Class II
- Regulation
- 21 CFR 890.5870
- Specialty
- Orthopedic Surgery
FDA's approval statement
As written in FDA's record.
Approval for an additional manufacturing site (Bioventus LLC, Cordova, Tennessee, FEI # 302669735) for the EXOGEN Ultrasound Bone Healing System.
Source documents
Other decisions for Bioventus, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253877 · Decided Aug 26, 2026 · 265 days after receipt
Device type: Stimulator, Peripheral Nerve, Implanted (Pain Relief) (GZF) · Neurology & Neurosurgery
6 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.